CBD oil products can be somewhat expensive, which may be a barrier for individuals seeking treatment or relief from different conditions and disorders. cbdMD is a notable exception as far as price-point is concerned. cbdMD offers it’s premium, non-THC oils at a large variety of concentrations (300mg-5,00mg) as well as sizes (30mL and 60mL) . These oils are priced at $28 for 300mg oils and $90 for 1,500mg oils; both price-points are significantly below average.
He emphasises that the company’s products are “whole-plant extracts that include a variety of phytochemicals, not just CBD. These beneficial compounds include a range of phytocannabinoids, terpenes and flavonoids that work together.” This isn’t necessarily seen as a positive by researchers, with McGuire saying: “They muddy the water.” However, Sativex is also a plant extract containing other cannabinoids and substances. David Potter, chief botanist at GW Pharmaceuticals, which makes the drug, says the evidence at the time the drug was developed “suggested there was a synergy between these active ingredients”.
I also have neuropathy. Mine is caused from Lyme, I have both Burgdorferri and Bartonella bacteria. First my feet went numb, kind-of. I guess I would describe it as feeling like I am walking on pebbles. Then my shins started. It is so painful and, of course, the doctors think I am lying so that I can score drugs. I am 65 years young. They also keep testing me for diabetes. My Hgb A1C is, and has always been, normal, along with my glucose levels. My shins were so painful that I would wake up frequently during the night. Soooo, I got myself some high CBD and low THC leaf. (Medical marijuana) I have tried rolling it and smoking it, I bought a small pipe and smoked it,
Despite this, CBD is something nobody knows much about, and certainly nobody is monitoring it properly. CBD is widely marketed as a supplement, despite the Food and Drug Administration saying it does not qualify as such (this is because it is an active ingredient in drugs which are either approved or under investigation to be approved). CBD goes largely unregulated by the agency; on the FDA’s FAQ page, a vague answer maintains there are “many factors in deciding whether or not to initiate an enforcement action.” The Department of Agriculture handles research grants and pilot programs for hemp, but that’s where its involvement ends.